Pune, India, November, 2017 /MRFR Press Release/- Market Research Future has a half cooked research report on the global dermabrasion market. The global dermabrasion market is growing continuously and expected to grow at a CAGR of 4.5% from 2017 to 2023.
A number of surgical procedure are available in the market for the treatment of various skin problems. Dermabrasion is an invasive surgical treatment for acne, surgical scars, actinic keratosis, rhinophyma, and others. It is also used for tattoo removal and sun damaged skin, and it also changes in the appearance of the skin by injuring using an abrasive. The procedure is performed under local anesthesia and may result in the sensitive and pink skin. It has various side effects such as skin decoloration, and skin numbness due to local anesthesia, which is performed by the well-qualified surgeon or dermatologist. Also, the procedure results are more reliable in the light-skinned individuals than the dark skin ones further reducing the adoption rate, thus restraining the market growth.
High cost of dermabrasion and available of alternative treatment such as laser surgery, moderate to deep skin peels, and the injection of fillers may restrain the market growth.
The global dermabrasion market is expected to grow at a CAGR of 4.5% during the forecast period.
Taste the market data and market information presented through more than 55 market data tables and figures spread over 101 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Dermabrasion market research report–Global forecast till 2023.”
Major Players in the Market:
Some of the key players in the global market are Photomedex, Inc (U.S.), Syneron Medical Ltd. (U.S.), Alma Lasers (Isreal), Genesis Biosystems, Inc. (U.S.), Cynosure, Inc. (U.S.), Medtronic (U.S.), and Cutera, Inc. (U.S.).
According to cancer research U.K. in 2012, over 14.1 million of new cancer cases was registered globally and the number is increasing continuously. Dermatology and cosmetology are receiving worldwide attention and there is a rise in the demand for affordable treatment, especially, in the developing countries across the globe. As per the World Health Organization (WHO), deaths from cancer worldwide are expected to rise to over 13.1 million by 2030. According to the article published in the Adolescent Health, Medicine and Therapeutics, acne vulgaris is the most common skin condition diagnosed in adolescents worldwide.
The Americas is the largest market owing to an increasing demand for skin resurfacing and rejuvenation procedures in the U.S. and increasing demand for non-invasive procedures for skin problems among women such as acne vulgaris and surgical scars.
Europe holds the second position in the market. The market in the European countries is increasing due to the increasing adoption of skin care and cosmetic procedures, availability of funds for research and development activities, and growing emphasis on skin care. Furthermore, the demand for dermatology procedures for skin resurfacing is in the European countries.
Asia Pacific market is expected show a positive growth in the market owing to rising awareness about advantages of dermabrasion and side effects, changing lifestyle, and the demand for new dermatology treatment for acne and skin pigmentation. Additionally, the availability of well-qualified cosmetic surgeons and dermatologists further stimulates the market growth. In Asia Pacific, Australia has the highest prevalence of skin cancer, which has been increasing continuously from the last few years, thus there is an extensive demand for dermatology procedures.
The demand for dermabrasion is found to be low in the Middle East & Africa.
The global market is segmented on the basis of devices, indication, and end user.
On the basis of devices, the market is segmented into manual dermabraders and motorized dermabraders. The manual dermabraders are further segmented into wire brush, diamond wheel or fraise, sterilized sandpaperm, salt crystals, and others.
On the basis of indication, the market is segmented into surgical scars, benign tumors, actinic keratosis, rhinophyma, perioral rhytides, and others.
On the basis of end user, the market is segmented into hospitals, dermatology clinics, home care, and others.
Access Report Details @